These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39006698)

  • 1. A Rare Case of Pleural Epithelioid Mesothelioma With a Prominent Myxoid Stroma Reported With Morphology, Fluorescent In Situ Hybridization, and Ultrastructural Findings.
    Sonobe H; Omote R; Habara T; Washio K; Yamazoe N; Matsumoto S; Nabeshima K; Toda H
    Cureus; 2024 Jun; 16(6):e62212. PubMed ID: 39006698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse intrapulmonary malignant mesothelioma presenting with miliary pulmonary nodules: A case report.
    Hida T; Hamasaki M; Matsumoto S; Abe S; Takakura K; Hiroshima K; Nabeshima K
    Pathol Int; 2015 Jun; 65(6):318-23. PubMed ID: 25759091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of malignant pleural effusion for early cytological diagnosis of mesothelioma
    Yabuuchi Y; Hiroshima K; Oshima H; Kanazawa J; Hayashihara K; Nakagawa T; Shimanouchi M; Usui S; Oh-Ishi S; Saito T; Hizawa N; Minami Y
    Oncol Lett; 2022 Dec; 24(6):440. PubMed ID: 36420072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant pleural mesothelioma showing rare morphology indistinguishable from myxofibrosarcoma concomitant with EGFR-mutated lung adenocarcinoma: A case report.
    Onagi H; Hayashi T; Saito T; Kishikawa S; Takamochi K; Suzuki K
    Int J Surg Case Rep; 2021 Aug; 85():106237. PubMed ID: 34333253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myxoid variant of peritoneal epithelioid malignant mesothelioma. A case report.
    Goldová B; Dundr P; Zikán M; Tomancová V
    Cesk Patol; 2014 Jul; 50(3):149-51. PubMed ID: 25186596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma.
    Yoshida M; Jimbo N; Tsukamoto R; Itoh T; Kawahara K; Mitsui S; Tanaka Y; Maniwa Y
    Diagn Pathol; 2023 Nov; 18(1):126. PubMed ID: 38017544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology.
    Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T
    Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytological Assessment of Desmoplastic Malignant Pleural Mesothelioma in an Autopsy Case.
    Kawamoto Y; Kure S; Katayama H; Kawahara K; Teduka K; Kunugi S; Onda M; Motoda N; Ohashi R
    J Nippon Med Sch; 2023 Feb; 89(6):616-622. PubMed ID: 34840219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant mesothelioma with a pronounced myxoid stroma: a clinical and pathological evaluation of 19 cases.
    Shia J; Qin J; Erlandson RA; King R; Illei P; Nobrega J; Yao D; Klimstra DS
    Virchows Arch; 2005 Nov; 447(5):828-34. PubMed ID: 16021506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
    Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
    Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization detection of chromosome 22 monosomy in pleural effusion cytology for the diagnosis of mesothelioma.
    Kinoshita Y; Hamasaki M; Matsumoto S; Yoshimura M; Sato A; Tsujimura T; Kamei T; Kawahara K; Iwasaki A; Nabeshima K
    Cancer Cytopathol; 2021 Jul; 129(7):526-536. PubMed ID: 33493384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse pleural thickening and thoracic contraction: An indistinguishable case from malignant pleural mesothelioma.
    Tada Y; Tagawa M; Yusa T; Yatomi M; Shimomura I; Suzuki T; Takeshita Y; Sato T; Shimada H; Hiroshima K
    SAGE Open Med Case Rep; 2020; 8():2050313X20948716. PubMed ID: 32922794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology.
    Aydogdu G; Özekinci S
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):10001-10007. PubMed ID: 37916370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Cytokeratin 20 Reactivity in Epithelioid Malignant Mesothelioma: A Case Report.
    Manur R; Lamzabi I
    Appl Immunohistochem Mol Morphol; 2019; 27(10):e93-e96. PubMed ID: 28248731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens.
    Berg KB; Churg AM; Cheung S; Dacic S
    Cancer Cytopathol; 2020 Feb; 128(2):126-132. PubMed ID: 31821740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma.
    Wu D; Hiroshima K; Yusa T; Ozaki D; Koh E; Sekine Y; Matsumoto S; Nabeshima K; Sato A; Tsujimura T; Yamakawa H; Tada Y; Shimada H; Tagawa M
    Ann Diagn Pathol; 2017 Feb; 26():31-37. PubMed ID: 28038708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma.
    Şeker NS; Tekin E; Ak G; Metintaş M; Metintaş S; Dündar E
    Diagn Cytopathol; 2024 Apr; 52(4):211-216. PubMed ID: 38243885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis of Sarcomatoid Malignant Mesothelioma With
    Chen KB; Huang YJ; Huang Y; Wu ZW; Jin XL; Zhang H; Xiang XP; Chen L; Chen L
    Int J Surg Pathol; 2021 Dec; 29(8):856-863. PubMed ID: 33729861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing for BAP1 loss and CDKN2A/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology.
    Chevrier M; Monaco SE; Jerome JA; Galateau-Salle F; Churg A; Dacic S
    Cancer Cytopathol; 2020 Dec; 128(12):939-947. PubMed ID: 32678499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.